Tardif, Jean-Claude

Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

Bergmark, B. A., Marston, N. A., Bramson, C. R., Curto, M., Ramos, V., Jevne, A., Kuder, J. F., Park, J.-G., Murphy, S. A., Verma, S., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 216

Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])

Parkash, R., Wells, G. A., Sapp, J. L., Healey, J. S., Tardif, J.-C., Greiss, I., Rivard, L., Roux, J.-F., Gula, L., Nault, I., et al. (2017) · Circulation

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 101

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

Majithia, A., Bhatt, D. L., Friedman, A. N., Miller, M., Steg, P. G., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., et al. (2021) · Circulation

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 74

Reproducibility of near-infrared spectroscopy parameters measured during brachial artery occlusion and reactive hyperemia in healthy men

Lacroix, S., Gayda, M., Gremeaux, V., Juneau, M., Nigam, A., & Tardif, J.-C. (2012) · Journal of Biomedical Optics

Cardiovascular and exercise physiologyOptical Imaging and Spectroscopy Techniques

Cited by 52

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

Selvaraj, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Juliano, R. A., Jiao, L., Tardif, J., Ballantyne, C. M., et al. (2022) · Journal of the American Heart Association

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 31

Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies

Catapano, A. L., Mikhailova, E., Navar, A. M., Banka, P., Corral, P., Saxena, M., Steg, P. G., Verma, S., Kordahi, A. Y., Mendizabal, G., et al. (2026) · JACC

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 19

COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN US REDUCE-IT PATIENTS

Weintraub, W. S., Bhatt, D., Zhang, Z., Zhang, C., Sarahfaye, D., Boden, W. E., Steg, P. G., Miller, M., Brinton, E., King, J., et al. (2020) · Journal of the American College of Cardiology

Fatty Acid Research and HealthHealth Systems, Economic Evaluations, Quality of Life

Cited by 13